- Home
- ETON vs TATT Comparison
ETON vs TATT Comparison
Compare ETON & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- TATT
- Stock Information
- Founded
- ETON 2017
- TATT 1985
- Country
- ETON United States
- TATT Israel
- Employees
- ETON N/A
- TATT N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- TATT Aerospace
- Sector
- ETON Health Care
- TATT Industrials
- Exchange
- ETON Nasdaq
- TATT Nasdaq
- Market Cap
- ETON 199.5M
- TATT 209.6M
- IPO Year
- ETON 2018
- TATT 1987
- Fundamental
- Price
- ETON $10.02
- TATT $20.61
- Analyst Decision
- ETON Strong Buy
- TATT
- Analyst Count
- ETON 3
- TATT 0
- Target Price
- ETON $12.00
- TATT N/A
- AVG Volume (30 Days)
- ETON 212.9K
- TATT 25.7K
- Earning Date
- ETON 11-12-2024
- TATT 11-18-2024
- Dividend Yield
- ETON N/A
- TATT N/A
- EPS Growth
- ETON N/A
- TATT 198.11
- EPS
- ETON N/A
- TATT 0.73
- Revenue
- ETON $34,677,000.00
- TATT $132,384,999.00
- Revenue This Year
- ETON $19.61
- TATT N/A
- Revenue Next Year
- ETON $82.71
- TATT N/A
- P/E Ratio
- ETON N/A
- TATT $28.13
- Revenue Growth
- ETON 5.64
- TATT 38.12
- 52 Week Low
- ETON $3.03
- TATT $9.08
- 52 Week High
- ETON $11.11
- TATT $23.00
- Technical
- Relative Strength Index (RSI)
- ETON 67.30
- TATT 61.35
- Support Level
- ETON $8.76
- TATT $17.71
- Resistance Level
- ETON $11.11
- TATT $23.00
- Average True Range (ATR)
- ETON 0.66
- TATT 1.07
- MACD
- ETON 0.10
- TATT 0.25
- Stochastic Oscillator
- ETON 62.02
- TATT 54.82
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About TATT TAT Technologies Ltd.
TAT Technologies Ltd is a provider of solutions and services to the aerospace and defence industries focused mainly on the four segments: Original equipment manufacturing (OEM); MRO services for heat transfer; MRO services for aviation components; Overhaul and coating of jet engine components. The company designs, develops, and manufactures Heat Exchangers, Cooling Systems, Cold Plates, Vapor-Cycle Air Conditioning Systems (for both land and airborne applications), and flow accessories.